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Dr Graudal’s hostile and scare-mongering article is full of inaccuracies, selected arguments 32 
and false statements. He considers the 2013 IOM Report, the remit of which was limited
1
, 33 
dismissing the positions of the previous IOM Report, the World Health Organization, the US 34 
CDC, the AHA, the British NICE and many other national health organizations statements 35 
which informed the 2011 United Nations resolution and the 2013 World Health Assembly 36 
deliberation that population salt reduction strategy is the second most effective strategy for 37 
the prevention of cardiovascular disease (CVD) globally. The presence of a food industry 38 
conspiracy biasing research and co-opting unscrupulous opinion leaders to divert attention 39 
from salt with surreptitious new theories has been extensively documented over the years
2
. 40 
On the contrary the alleged conspiracy of global health organizations in producing a sound 41 
piece of public health advice is another fabrication to divert attention again.  42 
 43 
Sodium chloride (salt) is not a nutrient. At the current levels added to food salt is a toxic 44 
chemical. Dr Graudal makes confusion between the concepts of usual/habitual and 45 
adequate/normal.  If we all smoked, smoking would be normal. If we were to define obesity 46 
today, we would have to raise the cut-off points for obesity in many countries. A body mass 47 
index of 30 kg/m
2
 would not indicate obesity because most people in the population weigh 48 
that much. If we were to define the adequate levels of physical activity, we should accept 49 
that the normality would be not exercising at all. So it is for salt intake! The usual/habitual 50 
levels are not adequate/normal levels. 51 
 52 
Dr Graudal continues to pursue two surreptitious arguments: a) that the effect of salt 53 
reduction on blood pressure (BP) is non-existent and b) that salt reduction increases 54 
hormones that could be dangerous. His first argument is answered in my Figure 1. For the 55 
second, he only quotes his meta-analyses including short-term acute studies of salt 56 
deprivation. I have already addressed the flaw of his argument and shown that the meta-57 
analyses published are consistent with each other that there is a beneficial effect on BP.  No 58 
need to remind Dr Graudal that treatment with diuretics reduces stroke mortality and other 59 
CVD events due to the fall in BP, despite a chronic stimulation of the renin-angiotensin-60 
aldosterone system, much greater than that seen with a moderate salt reduction. 61 
 62 
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There are published positions of the NHLBI, the TOHP and the DASH authors that dismiss the 63 
allegations Dr Graudal needlessly uses to win his argument. When referring to the ‘WASH’ 64 
group, he lumps together all those who do not agree with him (although separate and 65 
independent researchers around the world), as if they had been running studies altogether 66 
for 20 years! I would consider their results ‘consistent’ with each other. 67 
 68 
Dr Gradual maintains that population moderate salt reduction kills. This is an irresponsible 69 
statement based on few selected studies (mostly observational) that are flawed for the 70 
presence of biases and confounding (see my Table). In brief, in the EPOGH cohort, the 71 
lowest sodium intake tertile was flawed by urine under-collections (urinary creatinine in first 72 
tertile 12 v 16 mmol in third tertile) and lower socio-economic status
3
. In the analysis of 73 
ONTARGET/TRANSCEND studies participants were old and sick patients on multiple 74 
medications (29% on diuretics but 41% of them in the lowest sodium group)
4
 and sodium 75 
intake was estimated using inaccurate methods
5
. Finally the PURE Study
6-7
is flawed on many 76 
grounds. The sodium measurement by single fasting morning urine collection to assess 77 
individuals’ salt intake is unreliable and biased. The sodium study only included ~100,000 of 78 
the ~160,000 participants, introducing a self-selection bias, and there were fewer 79 
participants from India and more from China, the majority with ill-health (hypertension, BP 80 
medications, CHD, CVD). The lower sodium group (<3g per day equivalent to <7.5g salt per 81 
day) was unable to discriminate on a ‘low’ salt intake of <5g, hence the result are irrelevant 82 
to the debate on population salt reduction and targets. Finally, compared to the ‘higher’ 83 
sodium group, those in the ‘lower’ sodium group were older, had fewer men, Asians and 84 
smokers and higher LDL-cholesterol, history of CVD, diabetes, medication use, therefore 85 
biasing the ‘lower’ sodium group to older men with ill-health, hence the reverse causality 86 
risk of dying earlier!  87 
 88 
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